Clinical Outcomes In Patients With Ischemic Versus Non-ischemic Cardiomyopathy After Angiotensin Receptor-Neprilysin Inhibition Therapy

Author Information

Ibrahim Inanc MD, Phoenixville HospitalFollow
Asigul Yimit MD, Phoenixville HospitalFollow
Mohammad Memon MD, Phoenixville HospitalFollow
Gary S. Ledley MD, Phoenixville HospitalFollow
Daniel A. Ratliff MD, Phoenixville HospitalFollow

Keywords:

Angiotensin receptor-neprilysin inhibitor, ischemic cardiomyopathy, non-ischemic cardiomyopathy, one-year clinical outcomes

Recommended Citation

Inanc, Ibrahim MD; Yimit, Asigul MD; Memon, Mohammad MD; Ledley, Gary S. MD; and Ratliff, Daniel A. MD, "Clinical Outcomes In Patients With Ischemic Versus Non-ischemic Cardiomyopathy After Angiotensin Receptor-Neprilysin Inhibition Therapy" (2025). Tower Health Research Day. 33.
https://scholarcommons.towerhealth.org/th_researchday/2024-2025/in_person_posters/33

Institutional Review Board/Institutional Animal Care and Use Committee Approved or Exempt

IRB/IACUC approved